Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
Part of paid clinical trials in Castro Valley, California.
- Sponsor
- Bay Area Retina Associates
- Study ID
- NCT00390208
- Phase
- PHASE2
- Status
- Completed
Conditions
- Age Related Macular Degeneration
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ranibizumab, dexamethasone and verteporfin — DRUGOne 500 microgram dose (0.05cc) intravitreal dexamethasone (10 mg/ml vial) in combination with Visudyne Photodynamic Therapy and 0.5 mg intravitreal Ranibizumab injection on the same day.
- Ranibizumab — DRUGOne 0.5 mg intravitreal Ranibizumab injection
Study Details
The purpose of this study is to compare triple therapy using Photodynamic therapy, intravitreal Dexamethasone and intravitreal Ranibizumab injections versus monotherapy with intravitreal Ranibizumab alone for the treatment of Age-Related Macular Degeneration.
Key Dates
- Start date
- Aug 31, 2006
- Status verified
- May 2010
- Primary completion
- Dec 31, 2008
- Completion
- Dec 31, 2009
Study Design
- Enrollment
- 60 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Other: Group 1Combination triple therapy of Lucentis, Dexamethasone and Visudyne Therapy
- Other: Group 2Monotherapy: One 0.5 mg intravitreal Ranibizumab injection
Primary Outcome Measure
Visual Acuity: Change in visual acuity by 15 or more ETDRS letters at 6 and 12 months. Non-inferiority as compared to the triple therapy arm will serve to determine efficacy for the purposes of this pilot trial. [ Time Frame: one year ]
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Bay Area Retina Associates | Castro Valley | California | 94546 | - |
| Bay Area Retina Associates | Walnut Creek | California | 94598 | - |
| Georgia Retina | Riverdale | Georgia | 30274 | - |
| Retina Vitreous Associates | Toledo | Ohio | 43608 | - |
Find similar trials in Castro Valley, CA
Related Studies
- Strategies for Improving Linkage-to-Care After Eye Disease ScreeningRecruiting · University of California, San Francisco · San Francisco, California
- Phase 1 Study of C.001 in Retinal DegenerationPHASE1 · Recruiting · Cellio Therapeutics Inc · Beverly Hills, California